Version:

02-04-2014 07-04-2014 07-05-2018: MenC - 2nd dose introduction 01-11-2018: MenB introduction 01-01-2019: MenB and gender neutral HPV 04-11-2021: Updated recommendations for COVID-19 Vaccine 07-10-2022: Update recommendations for pneumococcal vaccination

Footnotes:

1. https://covid19.public.lu/fr/vaccination.html
2. for latest information refer to https://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/covid-19.html
3. Subsequent Tdacp-IPV booster every 10 years
4. Babies born to a mother infected with hepatitis B will be offered a first dose at birth
5. if no history of vaccination
6. For individuals from 18 years of age, immunosupporessed or with specific conditons putting them at risk of severe pneumococcal infection the following recommendations apply: For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
7. For people aged 65 years of age, update to the pneumococcal recommendations based on prior vaccination. please refer to the full recommendation available here: https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf
8. Two/three doses recommended in at-risk groups, depending on age. Further information available at: https://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite.html
9. see https://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite.html
10. Two/three doses recommended in at-risk groups, depending on age. Further information available at: http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-avis-vaccination-meningocoque-groupe-b.pdf
11. Given the resurgence of measles, all adults born after 1980 who have not received two doses of measles, mumps and rubella vaccines should recall the MMR vaccine
12. 9-valent. Gender-neutral (boys and girls) vaccination offered. Two doses with 6 months interval
13. Three doses
14. for immunosuppressed or ahead of period of immunosuppression. 2 doses 1-2 months apart.
15. 2 doses 6-8 months apart

More information available at:
https://sante.public.lu/fr/espace-citoyen/dossiers-thematiques/v/vaccination/calendrier-vaccinal.html


-------------------------------------------------------------------------------------------------------------------------

ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.

MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups
2022: Update to the pneumococcal vaccination policy. use of PCV20. refer to https://sante.public.lu/dam-assets/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/csmi-recommandation-vaccination-pcv-personnes-agees-ou-a-risque.pdf

Date of last update: 12 April 2023

-------------------------------------------------------------------------------------------------------------------------